Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 2 | CN | 04 May 2023 | |
Solid tumor | Phase 2 | CN | 24 Feb 2021 | |
KRAS G12C mutant non-squamous non-small cell lung cancer | Phase 1 | CN | 08 Jan 2024 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 03 Sep 2021 |